-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BNbmbVlX1LECJQKGUv94youK9xaLOUX513C1lUzCcjfegPUSvfBUmlSlRmpOnwJV CUYdus6gNtdx8br0BozPjw== 0001209499-03-000111.txt : 20030826 0001209499-03-000111.hdr.sgml : 20030826 20030826171237 ACCESSION NUMBER: 0001209499-03-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030822 FILED AS OF DATE: 20030826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIBAPHARM INC CENTRAL INDEX KEY: 0001116613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954805655 BUSINESS ADDRESS: STREET 1: 3300 WYLAND AVENUE STREET 2: C/O ICN PHARMACEUTICALS INC CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: 7144276236 MAIL ADDRESS: STREET 1: 3300 WYLAND AVENUE STREET 2: C/O ICN PHARMACEUTICALS INC CITY: COSTA MESA STATE: CA ZIP: 92626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIMITRIADIS ANDRE C CENTRAL INDEX KEY: 0000938132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31294 FILM NUMBER: 03867133 BUSINESS ADDRESS: STREET 1: 9955 SE WASHINGTON STREET 2: SUITE 201 CITY: PORTLAND STATE: OR ZIP: 97216 BUSINESS PHONE: 5032526233 MAIL ADDRESS: STREET 1: 9955 SE WASHINTON STREET 2: SUITE 201 CITY: PORTLAND STATE: OR ZIP: 97216 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2003-08-22 1 0001116613 RIBAPHARM INC RNA 0000938132 DIMITRIADIS ANDRE C 9955 SE WASHINTON SUITE 201 PORTLAND OR 97216 1 0 0 0 Common Stock 2003-08-22 4 J 0 10000 D 0 D Non-Qualified Stock Option (right to buy) 4.65 2003-08-22 4 D 0 15000 D 2004-02-21 2013-02-21 Common Stock 15000 0 D Non-Qualified Stock Option (right to buy) 4.95 2003-08-22 4 D 0 15000 D 2004-05-27 2013-05-27 Common Stock 15000 0 D Pursuant to the merger of Ribapharm Inc. and Rx Acquisition Corp. on August 22, 2003, these shares were converted into the right to receive $6.25 per share in cash. Under the terms of Ribapharm Inc.'s 2002 Stock Option and Award Plan, the reporting person may receive either a) cash or b) options to purchase common stock of ICN Pharmaceuticals, Inc. in connection with the merger of Ribapharm Inc. By: Michelle May For: Andre Dimitriadis 2003-08-26 EX-24 3 dimitriadis.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Mel Deutsch, William Comer, and Michelle May, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Ribapharm Inc. (the "Company"), Forms 3, 4, 5, and 144 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5, or 144 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5, and 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of May, 2003. /s/ ANDRE DIMITRIADIS - ------------------------------------------------------ ANDRE DIMITRIADIS -----END PRIVACY-ENHANCED MESSAGE-----